ArticleHealthcare (Basel, Switzerland)2025

Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis.

Yuncui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.